Symbol="STRO"
AssetType="Common Stock"
Name="Sutro Biopharma"
Description="Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California."
CIK="1382101"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="266439000"
EBITDA="-126070000"
PERatio="None"
PEGRatio="None"
BookValue="3.082"
DividendPerShare="0"
DividendYield="0"
EPS="-2.17"
RevenuePerShareTTM="1.386"
ProfitMargin="-1.746"
OperatingMarginTTM="-1.771"
ReturnOnAssetsTTM="-0.249"
ReturnOnEquityTTM="-0.641"
RevenueTTM="74549000"
GrossProfitTTM="-42520000"
DilutedEPSTTM="-2.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.149"
AnalystTargetPrice="18.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.05"
PriceToBookRatio="1.876"
EVToRevenue="2.289"
EVToEBITDA="-1.451"
Beta="0.881"
num_52WeekHigh="8.72"
num_52WeekLow="4.09"
num_50DayMovingAverage="5.0"
num_200DayMovingAverage="5.98"
SharesOutstanding="60417000"
DividendDate="None"
ExDividendDate="None"
symbol="STRO"
open="4.44"
high="4.57"
low="4.30"
price="4.41"
volume="346666.00"
latest_trading_day="2023-07-26"
previous_close="4.39"
change="0.02"
change_percent="0.4556%"
aroon_positive_momentum_days="45"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="45"
Volume_recent_avg="504466"
Change_recent_avg="-0.01"
Delta_recent_avg="0.32"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="45"
Aroon_momentum_negative="55"
image_negative_thumbnail_id_1="121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="539"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="994"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_positive_thumbnail_id_2="979"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
